Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
45
XTNT Quote, Financials, Valuation and Earnings
Last price:
$0.71
Seasonality move
:
18.73%
Day range:
$0.70 - $0.75
52-week range:
$0.34 - $0.95
Dividend yield:
0%
P/E ratio:
69.62x
P/S ratio:
0.78x
P/B ratio:
1.97x
Volume:
98.6K
Avg. volume:
211.9K
1-year change:
38.37%
Market cap:
$99.4M
Revenue:
$117.3M
EPS (TTM):
$0.01
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
XTNT
Xtant Medical Holdings, Inc.
|
$30.8M | -- | -2.42% | -100% | $1.50 |
|
CATX
Perspective Therapeutics, Inc.
|
$231.1K | -$0.35 | -9.65% | -37.91% | $12.3077 |
|
INFU
InfuSystem Holdings, Inc.
|
$36.7M | $0.05 | 8.36% | 39.86% | $14.20 |
|
SRTS
Sensus Healthcare, Inc.
|
$8.3M | -$0.05 | -36.14% | -25.98% | $7.33 |
|
VNRX
VolitionRX Ltd.
|
$714.1K | -$0.04 | 272.5% | -33.67% | $2.20 |
|
VTAK
Catheter Precision, Inc.
|
$310K | -$0.20 | 118.75% | -11.57% | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
XTNT
Xtant Medical Holdings, Inc.
|
$0.71 | $1.50 | $99.4M | 69.62x | $0.00 | 0% | 0.78x |
|
CATX
Perspective Therapeutics, Inc.
|
$2.8100 | $12.3077 | $208.9M | -- | $0.00 | 0% | 190.53x |
|
INFU
InfuSystem Holdings, Inc.
|
$8.77 | $14.20 | $178.3M | 33.54x | $0.00 | 0% | 1.32x |
|
SRTS
Sensus Healthcare, Inc.
|
$4.46 | $7.33 | $73.3M | 34.65x | $0.00 | 0% | 2.05x |
|
VNRX
VolitionRX Ltd.
|
$0.28 | $2.20 | $34M | -- | $0.00 | 0% | 18.97x |
|
VTAK
Catheter Precision, Inc.
|
$2.01 | -- | $2.5M | 0.40x | $0.00 | 0% | 9.45x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
XTNT
Xtant Medical Holdings, Inc.
|
39.2% | 3.120 | 35.76% | 1.08x |
|
CATX
Perspective Therapeutics, Inc.
|
1.35% | 3.042 | 1.3% | 8.47x |
|
INFU
InfuSystem Holdings, Inc.
|
30.8% | 4.042 | 11.73% | 1.35x |
|
SRTS
Sensus Healthcare, Inc.
|
1.03% | 1.475 | 1.03% | 4.98x |
|
VNRX
VolitionRX Ltd.
|
-48.16% | 2.723 | 15.4% | 0.04x |
|
VTAK
Catheter Precision, Inc.
|
68.63% | 0.156 | 537.37% | 0.41x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
XTNT
Xtant Medical Holdings, Inc.
|
$22M | $2.5M | 2.15% | 3.78% | 7.64% | $4.2M |
|
CATX
Perspective Therapeutics, Inc.
|
-$566K | -$27.9M | -37.13% | -37.63% | -13330.62% | -$18.3M |
|
INFU
InfuSystem Holdings, Inc.
|
$20.3M | $3.8M | 6.43% | 9.93% | 10.45% | $8.4M |
|
SRTS
Sensus Healthcare, Inc.
|
$2.7M | -$2.6M | -5.58% | -5.65% | -37.32% | $2.3M |
|
VNRX
VolitionRX Ltd.
|
$318.2K | -$5.1M | -- | -- | -813.17% | -$3.5M |
|
VTAK
Catheter Precision, Inc.
|
-$320K | -$3M | -79.27% | -192.05% | -1336.73% | -$2.2M |
Xtant Medical Holdings, Inc. vs. Competitors
-
Which has Higher Returns XTNT or CATX?
Perspective Therapeutics, Inc. has a net margin of 3.93% compared to Xtant Medical Holdings, Inc.'s net margin of -12425.36%. Xtant Medical Holdings, Inc.'s return on equity of 3.78% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.
Company Gross Margin Earnings Per Share Invested Capital XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M CATXPerspective Therapeutics, Inc.-270.81% -$0.35 $245.5M -
What do Analysts Say About XTNT or CATX?
Xtant Medical Holdings, Inc. has a consensus price target of $1.50, signalling upside risk potential of 111.24%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 338%. Given that Perspective Therapeutics, Inc. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe Perspective Therapeutics, Inc. is more attractive than Xtant Medical Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings XTNTXtant Medical Holdings, Inc.2 0 0 CATXPerspective Therapeutics, Inc.12 1 0 -
Is XTNT or CATX More Risky?
Xtant Medical Holdings, Inc. has a beta of -0.077, which suggesting that the stock is 107.701% less volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.182, suggesting its more volatile than the S&P 500 by 18.151%.
-
Which is a Better Dividend Stock XTNT or CATX?
Xtant Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings, Inc. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XTNT or CATX?
Xtant Medical Holdings, Inc. quarterly revenues are $33.3M, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. Xtant Medical Holdings, Inc.'s net income of $1.3M is higher than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, Xtant Medical Holdings, Inc.'s price-to-earnings ratio is 69.62x while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings, Inc. is 0.78x versus 190.53x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XTNTXtant Medical Holdings, Inc.0.78x 69.62x $33.3M $1.3M CATXPerspective Therapeutics, Inc.190.53x -- $209K -$26M
-
Which has Higher Returns XTNT or INFU?
InfuSystem Holdings, Inc. has a net margin of 3.93% compared to Xtant Medical Holdings, Inc.'s net margin of 6.19%. Xtant Medical Holdings, Inc.'s return on equity of 3.78% beat InfuSystem Holdings, Inc.'s return on equity of 9.93%.
Company Gross Margin Earnings Per Share Invested Capital XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M INFUInfuSystem Holdings, Inc.55.65% $0.11 $80.2M -
What do Analysts Say About XTNT or INFU?
Xtant Medical Holdings, Inc. has a consensus price target of $1.50, signalling upside risk potential of 111.24%. On the other hand InfuSystem Holdings, Inc. has an analysts' consensus of $14.20 which suggests that it could grow by 61.92%. Given that Xtant Medical Holdings, Inc. has higher upside potential than InfuSystem Holdings, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than InfuSystem Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings XTNTXtant Medical Holdings, Inc.2 0 0 INFUInfuSystem Holdings, Inc.5 0 0 -
Is XTNT or INFU More Risky?
Xtant Medical Holdings, Inc. has a beta of -0.077, which suggesting that the stock is 107.701% less volatile than S&P 500. In comparison InfuSystem Holdings, Inc. has a beta of 1.680, suggesting its more volatile than the S&P 500 by 68.01%.
-
Which is a Better Dividend Stock XTNT or INFU?
Xtant Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InfuSystem Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings, Inc. pays -- of its earnings as a dividend. InfuSystem Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XTNT or INFU?
Xtant Medical Holdings, Inc. quarterly revenues are $33.3M, which are smaller than InfuSystem Holdings, Inc. quarterly revenues of $36.5M. Xtant Medical Holdings, Inc.'s net income of $1.3M is lower than InfuSystem Holdings, Inc.'s net income of $2.3M. Notably, Xtant Medical Holdings, Inc.'s price-to-earnings ratio is 69.62x while InfuSystem Holdings, Inc.'s PE ratio is 33.54x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings, Inc. is 0.78x versus 1.32x for InfuSystem Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XTNTXtant Medical Holdings, Inc.0.78x 69.62x $33.3M $1.3M INFUInfuSystem Holdings, Inc.1.32x 33.54x $36.5M $2.3M
-
Which has Higher Returns XTNT or SRTS?
Sensus Healthcare, Inc. has a net margin of 3.93% compared to Xtant Medical Holdings, Inc.'s net margin of -13.7%. Xtant Medical Holdings, Inc.'s return on equity of 3.78% beat Sensus Healthcare, Inc.'s return on equity of -5.65%.
Company Gross Margin Earnings Per Share Invested Capital XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M SRTSSensus Healthcare, Inc.39.41% -$0.06 $51.7M -
What do Analysts Say About XTNT or SRTS?
Xtant Medical Holdings, Inc. has a consensus price target of $1.50, signalling upside risk potential of 111.24%. On the other hand Sensus Healthcare, Inc. has an analysts' consensus of $7.33 which suggests that it could grow by 64.42%. Given that Xtant Medical Holdings, Inc. has higher upside potential than Sensus Healthcare, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than Sensus Healthcare, Inc..
Company Buy Ratings Hold Ratings Sell Ratings XTNTXtant Medical Holdings, Inc.2 0 0 SRTSSensus Healthcare, Inc.2 0 0 -
Is XTNT or SRTS More Risky?
Xtant Medical Holdings, Inc. has a beta of -0.077, which suggesting that the stock is 107.701% less volatile than S&P 500. In comparison Sensus Healthcare, Inc. has a beta of 1.211, suggesting its more volatile than the S&P 500 by 21.098%.
-
Which is a Better Dividend Stock XTNT or SRTS?
Xtant Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sensus Healthcare, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings, Inc. pays -- of its earnings as a dividend. Sensus Healthcare, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XTNT or SRTS?
Xtant Medical Holdings, Inc. quarterly revenues are $33.3M, which are larger than Sensus Healthcare, Inc. quarterly revenues of $6.9M. Xtant Medical Holdings, Inc.'s net income of $1.3M is higher than Sensus Healthcare, Inc.'s net income of -$943K. Notably, Xtant Medical Holdings, Inc.'s price-to-earnings ratio is 69.62x while Sensus Healthcare, Inc.'s PE ratio is 34.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings, Inc. is 0.78x versus 2.05x for Sensus Healthcare, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XTNTXtant Medical Holdings, Inc.0.78x 69.62x $33.3M $1.3M SRTSSensus Healthcare, Inc.2.05x 34.65x $6.9M -$943K
-
Which has Higher Returns XTNT or VNRX?
VolitionRX Ltd. has a net margin of 3.93% compared to Xtant Medical Holdings, Inc.'s net margin of -862.39%. Xtant Medical Holdings, Inc.'s return on equity of 3.78% beat VolitionRX Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M VNRXVolitionRX Ltd.50.73% -$0.05 -$24.7M -
What do Analysts Say About XTNT or VNRX?
Xtant Medical Holdings, Inc. has a consensus price target of $1.50, signalling upside risk potential of 111.24%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.20 which suggests that it could grow by 694.8%. Given that VolitionRX Ltd. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe VolitionRX Ltd. is more attractive than Xtant Medical Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings XTNTXtant Medical Holdings, Inc.2 0 0 VNRXVolitionRX Ltd.4 2 0 -
Is XTNT or VNRX More Risky?
Xtant Medical Holdings, Inc. has a beta of -0.077, which suggesting that the stock is 107.701% less volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.234, suggesting its more volatile than the S&P 500 by 23.404%.
-
Which is a Better Dividend Stock XTNT or VNRX?
Xtant Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XTNT or VNRX?
Xtant Medical Holdings, Inc. quarterly revenues are $33.3M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. Xtant Medical Holdings, Inc.'s net income of $1.3M is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, Xtant Medical Holdings, Inc.'s price-to-earnings ratio is 69.62x while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings, Inc. is 0.78x versus 18.97x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XTNTXtant Medical Holdings, Inc.0.78x 69.62x $33.3M $1.3M VNRXVolitionRX Ltd.18.97x -- $627.3K -$5.4M
-
Which has Higher Returns XTNT or VTAK?
Catheter Precision, Inc. has a net margin of 3.93% compared to Xtant Medical Holdings, Inc.'s net margin of -1037.17%. Xtant Medical Holdings, Inc.'s return on equity of 3.78% beat Catheter Precision, Inc.'s return on equity of -192.05%.
Company Gross Margin Earnings Per Share Invested Capital XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M VTAKCatheter Precision, Inc.-141.59% -$1.70 $21.3M -
What do Analysts Say About XTNT or VTAK?
Xtant Medical Holdings, Inc. has a consensus price target of $1.50, signalling upside risk potential of 111.24%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 1790.6%. Given that Catheter Precision, Inc. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe Catheter Precision, Inc. is more attractive than Xtant Medical Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings XTNTXtant Medical Holdings, Inc.2 0 0 VTAKCatheter Precision, Inc.0 0 0 -
Is XTNT or VTAK More Risky?
Xtant Medical Holdings, Inc. has a beta of -0.077, which suggesting that the stock is 107.701% less volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.392, suggesting its less volatile than the S&P 500 by 239.195%.
-
Which is a Better Dividend Stock XTNT or VTAK?
Xtant Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings, Inc. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XTNT or VTAK?
Xtant Medical Holdings, Inc. quarterly revenues are $33.3M, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. Xtant Medical Holdings, Inc.'s net income of $1.3M is higher than Catheter Precision, Inc.'s net income of -$2.3M. Notably, Xtant Medical Holdings, Inc.'s price-to-earnings ratio is 69.62x while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings, Inc. is 0.78x versus 9.45x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XTNTXtant Medical Holdings, Inc.0.78x 69.62x $33.3M $1.3M VTAKCatheter Precision, Inc.9.45x 0.40x $226K -$2.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
69
RGC alert for Jan 7
Regencell Bioscience Holdings Ltd. [RGC] is up 58.95% over the past day.
Buy
69
WDC alert for Jan 7
Western Digital Corp. [WDC] is down 8.88% over the past day.
Buy
75
DRUG alert for Jan 7
Bright Minds Biosciences, Inc. [DRUG] is up 2.99% over the past day.
